Free Trial

Smart for Life (SMFL) Competitors

Smart for Life logo
$0.02
-0.01 (-16.67%)
(As of 12:56 PM ET)

SMFL vs. REVB, QLGN, HSTO, ASLN, PXMD, EVFM, ADXS, ADTX, PBLA, and NMTR

Should you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include Revelation Biosciences (REVB), Qualigen Therapeutics (QLGN), Histogen (HSTO), ASLAN Pharmaceuticals (ASLN), PaxMedica (PXMD), Evofem Biosciences (EVFM), Ayala Pharmaceuticals (ADXS), Aditxt (ADTX), Panbela Therapeutics (PBLA), and 9 Meters Biopharma (NMTR). These companies are all part of the "pharmaceutical products" industry.

Smart for Life vs.

Revelation Biosciences (NASDAQ:REVB) and Smart for Life (NASDAQ:SMFL) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, community ranking, valuation, media sentiment, earnings, analyst recommendations and profitability.

Revelation Biosciences has higher earnings, but lower revenue than Smart for Life. Revelation Biosciences is trading at a lower price-to-earnings ratio than Smart for Life, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Revelation BiosciencesN/AN/A-$120K-$28.53-0.03
Smart for Life$11.11M0.02-$22.68M-$1.12 thousand0.00

12.8% of Revelation Biosciences shares are held by institutional investors. Comparatively, 28.4% of Smart for Life shares are held by institutional investors. 0.2% of Revelation Biosciences shares are held by company insiders. Comparatively, 31.7% of Smart for Life shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Smart for Life's return on equity of 0.00% beat Revelation Biosciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Revelation BiosciencesN/A -152.41% -74.43%
Smart for Life N/A N/A N/A

In the previous week, Smart for Life had 1 more articles in the media than Revelation Biosciences. MarketBeat recorded 1 mentions for Smart for Life and 0 mentions for Revelation Biosciences. Smart for Life's average media sentiment score of 0.87 beat Revelation Biosciences' score of 0.00 indicating that Smart for Life is being referred to more favorably in the news media.

Company Overall Sentiment
Revelation Biosciences Neutral
Smart for Life Positive

Revelation Biosciences received 29 more outperform votes than Smart for Life when rated by MarketBeat users. However, 100.00% of users gave Smart for Life an outperform vote while only 63.83% of users gave Revelation Biosciences an outperform vote.

CompanyUnderperformOutperform
Revelation BiosciencesOutperform Votes
30
63.83%
Underperform Votes
17
36.17%
Smart for LifeOutperform Votes
1
100.00%
Underperform Votes
No Votes

Revelation Biosciences has a beta of 0.15, indicating that its stock price is 85% less volatile than the S&P 500. Comparatively, Smart for Life has a beta of 0.96, indicating that its stock price is 4% less volatile than the S&P 500.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Revelation Biosciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Smart for Life
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

Smart for Life beats Revelation Biosciences on 10 of the 13 factors compared between the two stocks.

Get Smart for Life News Delivered to You Automatically

Sign up to receive the latest news and ratings for SMFL and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SMFL vs. The Competition

MetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ Exchange
Market Cap$213,000.00$1.22B$4.97B$8.41B
Dividend YieldN/AN/A7.49%4.16%
P/E Ratio0.0034.85122.3916.51
Price / Sales0.023.451,636.5775.76
Price / CashN/A15.5336.9033.53
Price / Book0.002.094.575.13
Net Income-$22.68M-$50.21M$112.22M$223.04M
7 Day PerformanceN/A11.24%115.70%3.32%
1 Month PerformanceN/A30.41%129.43%8.60%
1 Year PerformanceN/A15.18%157.41%28.76%

Smart for Life Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SMFL
Smart for Life
N/A$0.03
-16.7%
N/A-99.8%$177,000.00$11.11M0.00110Gap Down
REVB
Revelation Biosciences
0.861 of 5 stars
$0.84
+0.8%
N/A-95.4%$1.37MN/A-0.0310Positive News
QLGN
Qualigen Therapeutics
N/A$0.10
-6.8%
N/A-86.0%$1.29M$4.98M0.0050Stock Split
News Coverage
Gap Down
HSTO
Histogen
N/A$0.30
flat
N/A-35.6%$1.28M$19,000.00-0.117
ASLN
ASLAN Pharmaceuticals
1.2298 of 5 stars
$0.60
flat
$76.00
+12,566.7%
N/A$1.23M$12M-0.0330
PXMD
PaxMedica
1.327 of 5 stars
$0.10
+4.4%
$3.00
+2,773.6%
-95.5%$1.18MN/A0.002
EVFM
Evofem Biosciences
0.7668 of 5 stars
$0.01
+10.4%
N/A-80.6%$1.17M$18.22M-0.02120Gap Down
ADXS
Ayala Pharmaceuticals
N/A$0.03
-53.0%
N/A-97.0%$1.15M$3.24M0.0020Analyst Forecast
News Coverage
Gap Down
ADTX
Aditxt
0.1505 of 5 stars
$0.58
-19.4%
N/A-99.8%$1.15M$329,739.000.0047High Trading Volume
PBLA
Panbela Therapeutics
0.9625 of 5 stars
$0.32
-6.6%
$500.00
+156,150.0%
-97.4%$1.11MN/A0.007Gap Up
NMTR
9 Meters Biopharma
N/AN/AN/AN/A$1.04MN/A-0.0220

Related Companies and Tools


This page (NASDAQ:SMFL) was last updated on 11/4/2024 by MarketBeat.com Staff
From Our Partners